UICC | N (%) | Median survival in months (range) | Log-rank test (p value) | Cox regression analysis (p value) | 1-year survival (%) | 3-year survival (%) | 5-year survival (%) |
---|---|---|---|---|---|---|---|
Patients edition | 0.02 | 0.27 | |||||
T1 | 52 (53.1%) | 47.30 (0.30–149.29) | 86.5 | 44.2 | 19.2 | ||
T2 | 15 (15.3%) | 15.60 (0.23–97.05) | 60.0 | 20.0 | 13.3 | ||
T3 | 25 (25.5%) | 24.80 (0.16–150.11) | 64.0 | 24.0 | 12.0 | ||
T4 | 6 (6.1%) | 26.95 (3.84–43.17) | 66.7 | 33.3 | 0.0 | ||
7th edition | 0.004 | 0.09 | |||||
T1 | 48 (49.0%) | 50.40 (0.30–149.29) | 85.4 | 47.9 | 20.8 | ||
T2 | 38 (38.8%) | 19.88 (0.16–150.11) | 63.2 | 23.7 | 13.2 | ||
T3 | 10 (10.2%) | 21.62 (2.69–43.17) | 70.0 | 20.0 | 0.0 | ||
T4 | 2 (2.0%) | 19.86 (19.38–20.34) | 100.0 | 0.0 | 0.0 | ||
6th edition | 0.05 | 0.74 | |||||
N0 | 72 (73.5%) | 41.26 (0.16–149.29) | 77.8 | 36.1 | 18.1 | ||
N1 | 26 (26.5%) | 22.70 (2.69–150.11) | 69.2 | 30.8 | 7.7 | ||
7th edition | 0.05 | 0.74 | |||||
N0 | 72 (73.5%) | 41.26 (0.16–149.29) | 77.8 | 36.1 | 18.1 | ||
N1 | 26 (26.5%) | 22.70 (2.69–150.11) | 69.2 | 30.8 | 7.7 | ||
6th edition | 0.21 | N/a | |||||
M0 | 96 (98.0%) | 27.79 (0.16–150.11) | 76.0 | 35.4 | 15.6 | ||
M1 | 2 (2.0%) | 15.29 (2.69–27.89) | 50.0 | 0.0 | 0.0 | ||
7th edition | 0.45 | N/a | |||||
M0 | 91 (92.9%) | 27.79 (0.16–150.11) | 76.9 | 34.1 | 16.5 | ||
M1 | 7 (7.1%) | 27.89 (2.69–54.97) | 57.1 | 42.9 | 0.0 |